Autopsy report · NCT03827213

Exparel Interscalene vs Indwelling Catheter

“Ran out of medication”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 4 months before it stopped.
• 23 participants enrolled.
• Results were posted on the registry 1 year 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Montefiore Medical Center

Sponsor type

University, hospital or other

Conditions

Pain

Interventions

Exparel; Indwelling Interscalene Catheter

Participants

23

Sites

1

Countries

United States

Trials that died the same way

• Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
  “Drug was no longer available” (70% match in meaning)
• TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)
  “Drug no longer available” (66% match in meaning)
• Program to Improve Dental Care: Children With ASD
  “ran out of money” (65% match in meaning)
• Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
  “Drug was not available.” (63% match in meaning)
• Role of Oxytocin in Telling and Detecting Lies
  “Drug not available” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.